Latest Articles

  • Is niacin ineffective? Or did AIM-HIGH miss its target?
    Stephen J. Nicholls, MBBS, PhD
    Cleveland Clinic Journal of Medicine January 2012, 79 (1) 38-43; DOI: https://doi.org/10.3949/ccjm.79a.11166

    The AIM-HIGH trial (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Health Outcomes) found, in an interim analysis, no cardiovascular benefit from taking extended-release niacin (Niaspan). In fact, there was a trend toward a greater risk of ischemic stroke, which did not reach statistical significance. But questions remain about this complex trial, which included intensive statin therapy in the active-treatment group and the control group.

  • Bugs, pundits, evolution, and the New Year
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine January 2012, 79 (1) 10; DOI: https://doi.org/10.3949/ccjm.79b.12001
  • Overcoming barriers to hypertension control in African Americans
    Taiye Odedosu, MD, Antoinette Schoenthaler, EdD, Dorice L. Vieira, MLS, MPH, MA, Charles Agyemang, PhD and Gbenga Ogedegbe, MD
    Cleveland Clinic Journal of Medicine January 2012, 79 (1) 46-56; DOI: https://doi.org/10.3949/ccjm.79a.11068
  • Diffuse reticulonodular infiltrates
    Maria Giselle S. Velez, MD, FACP and Vicente Jose M. Velez, MD, FACP
    Cleveland Clinic Journal of Medicine January 2012, 79 (1) 16-17; DOI: https://doi.org/10.3949/ccjm.78a.11009
  • Managing community-acquired pneumonia during flu season
    Sarah Haessler, MD and Jennifer J. Schimmel, MD
    Cleveland Clinic Journal of Medicine January 2012, 79 (1) 67-78; DOI: https://doi.org/10.3949/ccjm.79a.11108
  • Skin and soft-tissue infections: Classifying and treating a spectrum
    Sabitha Rajan, MD, MSc, FHM
    Cleveland Clinic Journal of Medicine January 2012, 79 (1) 57-66; DOI: https://doi.org/10.3949/ccjm.79a.11044
  • Cytomegalovirus colitis
    Jana G. Hashash, MD, Marwan Refaat, MD, Abdulrahman Abdulbaki, MD, Elie G. Aoun, MD and Leonard Baidoo, MD
    Cleveland Clinic Journal of Medicine January 2012, 79 (1) 12-13; DOI: https://doi.org/10.3949/ccjm.78a.11028
  • Correction
    Cleveland Clinic Journal of Medicine January 2012, 79 (1) 78; DOI: https://doi.org/10.3949/ccjm.79c.01001
  • In reply: The negative U wave in the setting of demand ischemia (August 2011)
    Sridhar Venkatachalam, MD, MRCP and Curtis M. Rimmerman, MD, MBA
    Cleveland Clinic Journal of Medicine December 2011, 78 (12) 785; DOI: https://doi.org/10.3949/ccjm.78c:12004
  • Essential tremor: Choosing the right management plan for your patient
    Essential tremor: Choosing the right management plan for your patient
    Hesham Abboud, MD, Anwar Ahmed, MD and Hubert H. Fernandez, MD
    Cleveland Clinic Journal of Medicine December 2011, 78 (12) 821-828; DOI: https://doi.org/10.3949/ccjm.78a.10178

    Successful management entails excluding secondary causes, carefully selecting drug therapy, and, in severe resistant or atypical cases, referring to a specialist.

Pages